Immunotherapy in the critically ill cancer patient: What the intensivist should know.

Nievas MV, García-Roche A, Jiménez-López M, Díaz-Lagares C

Open source

DOI
10.1016/j.medine.2026.502518
Published
2026 Sep 9
Container
Medicina intensiva
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.medine.2026.502518,
  title = {Immunotherapy in the critically ill cancer patient: What the intensivist should know.},
  author = {Nievas MV and García-Roche A and Jiménez-López M and Díaz-Lagares C},
  year = {2026},
  journal = {Medicina intensiva},
  doi = {10.1016/j.medine.2026.502518},
  url = {https://doi.org/10.1016/j.medine.2026.502518}
}

RIS

TY  - JOUR
TI  - Immunotherapy in the critically ill cancer patient: What the intensivist should know.
AU  - Nievas MV
AU  - García-Roche A
AU  - Jiménez-López M
AU  - Díaz-Lagares C
PY  - 2026
JO  - Medicina intensiva
DO  - 10.1016/j.medine.2026.502518
UR  - https://doi.org/10.1016/j.medine.2026.502518
ER  - 

APA

MV, N., A, G., M, J., & C, D. (2026). Immunotherapy in the critically ill cancer patient: What the intensivist should know.. Medicina intensiva. https://doi.org/10.1016/j.medine.2026.502518

Source records